ADHD Congress 2018 by Paragon Group
OVERVIEW
International Attention Deficit Hyperactivity Disorder (ADHD) Congress is organized by Paragon Group and will be held during Mar 19 - 21, 2018 at Dan Panorama Tel Aviv, Tel Aviv, Israel.
The target audience for this medical event is for the professionals who have interest in ADHD from all relevant fields: Adult/Pediatric Neurology, Adult/Pediatric Psychiatry, Pediatrics, Family Medicine, Epidemiology, Ethics, Psychology, Education, Nursing, Neuro-Science. This CME Conference has been approved for a maximum of 13 European CME credits.
The International ADHD Congress will continue the longstanding tradition of the ENAA meetings, in which it is the 5th, where numerous interesting and updated topics will be addressed.
The International ADHD Congress is focused on the triangle of symptoms, impairment and dysregulation which are all expressions of ADHD, their contribution to the clinical picture, their part in the diagnostic procedures and their response to treatment. Both clinical and neuro-biological aspects will be addressed. New developments in imaging, basic sciences, and clinical assessment and treatment will be highlighted, with special attention given to the worldwide prevalence of ADHD, as a chronic and disabling disorder which raises similar issues across different countries and cultures.
Conference Topics :
• Non-pharmacological Treatments.
• Treatments.
• Adults ADHD.
• Comorbidities.
• Family and ADHD.
• Neurocognitive aspects of ADHD.
• International Perspectives of ADHD.
• ADHD in Preschoolers.
• ADHD and Risk Taking.
• Basic Sciences and classification.
Conference Objectives are :
• Evaluate and review current data on ADHD from etiological, functional and clinical aspects, as well as different interventions and treatments with regard to their applicability in practice. An emphasis will be put on transition from childhood to adulthood.
• Evaluate current status of evaluation and treatment of ADHD worldwide.
• Summarize new research relating to a wide variety of topics including fMRI of the grey and the white matter, neurobiological and neurocognitive markers, personalized medicine, risks scores for predicting adult ADHD, evaluation and treatment of ADHD in different age groups including preschoolers and older adults, comorbidities, pharmacological and non-pharmacological treatments for ADHD, cultural variations in ADHD worldwide.
Additional details will be posted as soon as they are available.
The target audience for this medical event is for the professionals who have interest in ADHD from all relevant fields: Adult/Pediatric Neurology, Adult/Pediatric Psychiatry, Pediatrics, Family Medicine, Epidemiology, Ethics, Psychology, Education, Nursing, Neuro-Science. This CME Conference has been approved for a maximum of 13 European CME credits.
The International ADHD Congress will continue the longstanding tradition of the ENAA meetings, in which it is the 5th, where numerous interesting and updated topics will be addressed.
The International ADHD Congress is focused on the triangle of symptoms, impairment and dysregulation which are all expressions of ADHD, their contribution to the clinical picture, their part in the diagnostic procedures and their response to treatment. Both clinical and neuro-biological aspects will be addressed. New developments in imaging, basic sciences, and clinical assessment and treatment will be highlighted, with special attention given to the worldwide prevalence of ADHD, as a chronic and disabling disorder which raises similar issues across different countries and cultures.
Conference Topics :
• Non-pharmacological Treatments.
• Treatments.
• Adults ADHD.
• Comorbidities.
• Family and ADHD.
• Neurocognitive aspects of ADHD.
• International Perspectives of ADHD.
• ADHD in Preschoolers.
• ADHD and Risk Taking.
• Basic Sciences and classification.
Conference Objectives are :
• Evaluate and review current data on ADHD from etiological, functional and clinical aspects, as well as different interventions and treatments with regard to their applicability in practice. An emphasis will be put on transition from childhood to adulthood.
• Evaluate current status of evaluation and treatment of ADHD worldwide.
• Summarize new research relating to a wide variety of topics including fMRI of the grey and the white matter, neurobiological and neurocognitive markers, personalized medicine, risks scores for predicting adult ADHD, evaluation and treatment of ADHD in different age groups including preschoolers and older adults, comorbidities, pharmacological and non-pharmacological treatments for ADHD, cultural variations in ADHD worldwide.
Additional details will be posted as soon as they are available.
KEY DATES
19 Mar, 2018
Event Start Date
21 Mar, 2018
Event End Date
SPECIALITIES
PsychiatrySUGGESTED HOTELS
CONFERENCE VENUE
Dan Panorama HotelRELATED CONFERENCES & LIVE WEBINARS
Quick Links